For investors looking for a methodical way to find stocks with high growth, the approach detailed in Louis Navellier's "The Little Book That Makes You Rich" presents a strong framework. The plan is founded on eight basic rules meant to find companies showing better financial momentum, from good earnings revisions and surprises to faster sales and rising profitability. By sorting the market using this view, investors try to identify stocks in the beginning phases of a strong growth path. A recent filter using these strict conditions has identified XOMA Royalty Corp (NASDAQ:XOMAO) as a significant candidate, deserving a more detailed look at its fit with Navellier's rules.
Fit with the "Little Book" Growth Rules
The heart of Navellier's plan is a many-sided check on a company's financial condition and momentum. XOMAO's recent results show a clear fit with a number of these important rules, according to the supplied filter data:
-
Positive Earnings Revisions & Surprises: The plan gives great weight to analyst opinion and a company's capacity to regularly beat forecasts. XOMAO does very well here, with data showing the average EPS estimate beat over the previous four quarters at a large 623.8%. Also, analysts have greatly increased their next-quarter EPS estimates by 126.3% over the last three months. This pairing of large positive surprises and strong upward revisions is a key part of the growth investor's argument, pointing to fundamental business health the market may not yet fully recognize.
-
Strong Sales and Earnings Growth: A genuine growth stock must show quickening top and bottom-line increase. XOMAO's numbers are solid:
- Revenue increased 74.0% year-over-year (TTM) and 57.9% quarter-over-quarter.
- Earnings per share increased 170.9% year-over-year and 157.8% quarter-over-quarter. This forceful growth in both sales and profit is precisely what the method looks for, showing the company is not only raising sales but doing so with profit.
-
Rising Profitability and Good Cash Flow: Navellier's rules demand that sales growth leads to better margins and cash production. XOMAO's operating margin increase over the past year is noted at 152.5%, a signal of major operational leverage and gaining efficiency. Also, its free cash flow increased by 108.5% over the same time. Good and increasing cash flow supplies the means for future growth, lowers financial risk, and is a vital quality check in the plan.
-
Positive Earnings Momentum and High ROE: The plan searches for quickening, not just increase. XOMAO's current quarterly EPS growth (157.8%) greatly exceeds its growth from the same quarter a year earlier (8.2%), showing strong positive momentum. Finally, with a Return on Equity (ROE) of 17.8%, the company meets the "high ROE" standard, proving it can produce considerable profits from shareholder equity.
Fundamental Condition and Valuation Setting
Beyond the specific filter conditions, a wider view of XOMA Royalty Corp's fundamental picture gives important setting. According to ChartMill's detailed fundamental analysis report, XOMAO gets an overall score of 6 out of 10. The report points out several positives that support the growth filter findings:
- Profitability: The company scores well on profit measures, with a Profit Margin of 35.5% and an Operating Margin of 21.8%, each doing better than most of its biotechnology industry group. Its ROE and Return on Assets are also clearly good.
- Growth: The fundamental report confirms "very strong growth" in both revenue and EPS over the past year, matching the filter's results exactly.
- Dividend: Notably, XOMAO provides a yearly dividend yield of 8.24%, which is high for its industry and includes an income part not usually linked to early-phase growth stocks.
- Points to Watch: The report also notes items for investors to watch, including a high debt-to-free-cash-flow ratio and an Altman-Z score that points to financial risk. Valuation is mixed; while its Price/Earnings ratio of 17.6 is under the industry and S&P 500 averages, its forward P/E is high based on expected short-term earnings decrease.
Investment Picture and Following Actions
XOMA Royalty Corp shows a distinct picture at the meeting point of several plans. It meets a strict growth momentum filter based on Navellier's method, showing very fast recent growth in sales, earnings, and cash flow, together with strongly positive analyst surprises. Its high dividend yield further sets it apart from common pre-profitability biotech companies. This mix may draw both growth-focused investors and those looking for growth-with-income.
However, the fundamental analysis shows this is not without risk. The company's financial health score is middling, with clear solvency questions, and future earnings forecasts currently predict a drop. This highlights a key idea of the "Little Book" plan: the filter is a beginning for research, not a final action signal. It finds companies with strong quantitative momentum, but more careful research on the continuation of that momentum, the line of its royalty assets, and its balance sheet handling is necessary.
For investors wanting to look at other companies that currently meet this "Little Book" growth filter, you can see and adjust the live screening results here.
,
Disclaimer: This article is for informational purposes only and does not constitute financial advice, a recommendation, or an offer or solicitation to buy or sell any securities. The information presented is based on data provided and should not be the sole basis for any investment decision. Investing involves risk, including the potential loss of principal. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.